SCHEMBL30730989

SCHEMBL30730989

CCCc1cc(OC)c(CC(N)CC)cc1OC

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.56
TAAR1 Q96RJ0 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11736573 1.00 HTR2A (0.56) HTR2ATAAR1
SCHEMBL31455988 0.91 HTR2A (0.48) HTR2ATAAR1
SCHEMBL11739316 0.90 HTR2A (0.66) HTR2ATAAR1
SCHEMBL31456096 0.89 HTR2A (0.47) HTR2ATAAR1
SCHEMBL26612118 0.89 HTR2A (0.73) HTR2ATAAR1
SCHEMBL27187634 0.88 HTR2A (0.55) HTR2ATAAR1
SCHEMBL30852303 0.87 HTR2A (0.76) HTR2ATAAR1
SCHEMBL27002111 0.87 HTR2A (0.76) HTR2ATAAR1
SCHEMBL30852265 0.87 HTR2A (0.76) HTR2ATAAR1
SCHEMBL31456032 0.87 HTR2A (0.57) HTR2ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059373-A1 NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2025-03-20 WO disclosed
CN-119497589-A Therapeutic combinations, compositions and methods for designing and producing conditions that promote mental well-being 心境设计实验室股份有限公司 2025-02-21 CN disclosed
CN-117642379-A Phenylalkylamines and methods of making and using the same 吉尔伽美什制药公司 2024-03-01 CN disclosed